3-Chloro-4-ethylaniline - CAS 50775-72-9
Catalog: |
BB062427 |
Product Name: |
3-Chloro-4-ethylaniline |
CAS: |
50775-72-9 |
Synonyms: |
3-chloro-4-ethylaniline; 3-Chloro-4-ethylbenzenamine; Benzenamine, 3-chloro-4-ethyl- |
IUPAC Name: | 3-chloro-4-ethylaniline |
Description: | 3-Chloro-4-ethylaniline can be used for antitumor activity. |
Molecular Weight: | 155.62 |
Molecular Formula: | C8H10NCl |
Canonical SMILES: | CCC1=C(C=C(C=C1)N)Cl |
InChI: | InChI=1S/C8H10ClN/c1-2-6-3-4-7(10)5-8(6)9/h3-5H,2,10H2,1H3 |
InChI Key: | LBGGMEGRRIBANG-UHFFFAOYSA-N |
References: | Menta, E., et.al. WIPO WO2000053581 A2, (2000). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021053234-A1 | Compounds and compositions for treating kidney disease | 20190919 |
WO-2015007219-A1 | Quinazoline derivatives, compositions thereof, and use as pharmaceuticals | 20130718 |
MX-2014015350-A | TRIAZOLONE COMPOUNDS AS INHIBITORS OF MPEGS-1. | 20120615 |
WO-2010142752-A1 | Janus kinase inhibitor compounds and methods | 20090611 |
WO-2007106705-A1 | Soluble epoxide hydrolase inhibitors and methods of using same | 20060310 |
EP-1914221-A1 | Process for producing biaryl compound | 20050720 |
JP-2007051130-A | Process for producing biaryl compounds | 20050720 |
JP-5125008-B2 | Process for producing biaryl compounds | 20050720 |
US-2010087680-A1 | Method for producing biaryl compound | 20050720 |
EP-1173420-A2 | Heterocyclic compounds having antitumor activity | 19990305 |
Complexity: | 105 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 155.050177 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 155.050177 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 26Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS